sales@fusionmarketresearch.com

+1 210-775-2636 (USA)

2021-2030 Report on Global Biopharmaceutical CMO & CRO Market by Player, Region, Type, Application and Sales Channel   

Report Code : FMR56482 Publish By : MAResearch

Report to be delivered immediately.

The global Biopharmaceutical CMO & CRO market was valued at $XX million in 2020, and FMR analysts predict the global market size will reach $XX million by the end of 2030, growing at a CAGR of XX% between 2021 and 2030.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to all countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect this industry in 2020 and 2021.

This report analyses the impact of COVID-19 on this industry. COVID-19 can affect the global market in 3 ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on enterprises and financial markets.

This report provides detailed historical analysis of global market for Biopharmaceutical CMO & CRO from 2015-2020, and provides extensive market forecasts from 2021-2030 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Biopharmaceutical CMO & CRO market.

Leading players of Biopharmaceutical CMO & CRO including:
Boehringer Ingelheim
Lonza
Inno Biologics
Rentschler Biotechnologie
JRS PHARMA
BIOMEVA
ProBioGen
FUJIFILM Diosynth Biotechnologies
TOYOBO
Samsung BioLogics
Thermo Fisher Scientific (Patheon)
AGC Biologics (CMC Biologics)
Binex
WuXi Biologics
AbbVie
Charles River Laboratories
ICON plc
Pharmaceutical Product Development
Laboratory Corporation of America Holdings
PAREXEL International Corporation
PRA Health Sciences
GenScript
IDTDNA
Eufin
TWIST
ABCam
BioRab
GeneWiz

Market split by Type, can be divided into:
Contract Manufacturing
Contract Research

Market split by Application, can be divided into:
Biologics
Biosimilars

Market split by Sales Channel, can be divided into:
Direct Channel
Distribution Channel

Market segment by Region/Country including:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America (Brazil, Argentina and Colombia etc.)
Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)

If you have any special requirements, please let us know and we can provide you the customized report as you want.

Free Sample Reports

Table of Contents

Chapter 1 Biopharmaceutical CMO & CRO Market Overview
1.1 Biopharmaceutical CMO & CRO Definition
1.2 Global Biopharmaceutical CMO & CRO Market Size Status and Outlook (2015-2030)
1.3 Global Biopharmaceutical CMO & CRO Market Size Comparison by Region (2015-2030)
1.4 Global Biopharmaceutical CMO & CRO Market Size Comparison by Type (2015-2030)
1.5 Global Biopharmaceutical CMO & CRO Market Size Comparison by Application (2015-2030)
1.6 Global Biopharmaceutical CMO & CRO Market Size Comparison by Sales Channel (2015-2030)
1.7 Biopharmaceutical CMO & CRO Market Dynamics (COVID-19 Impacts)
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts on Current Market
1.7.5 Post-Strategies of COVID-19 Outbreak
Chapter 2 Biopharmaceutical CMO & CRO Market Segment Analysis by Player
2.1 Global Biopharmaceutical CMO & CRO Sales and Market Share by Player (2018-2020)
2.2 Global Biopharmaceutical CMO & CRO Revenue and Market Share by Player (2018-2020)
2.3 Global Biopharmaceutical CMO & CRO Average Price by Player (2018-2020)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Biopharmaceutical CMO & CRO Market Segment Analysis by Type
3.1 Global Biopharmaceutical CMO & CRO Market by Type
3.1.1 Contract Manufacturing
3.1.2 Contract Research
3.2 Global Biopharmaceutical CMO & CRO Sales and Market Share by Type (2015-2020)
3.3 Global Biopharmaceutical CMO & CRO Revenue and Market Share by Type (2015-2020)
3.4 Global Biopharmaceutical CMO & CRO Average Price by Type (2015-2020)
3.5 Leading Players of Biopharmaceutical CMO & CRO by Type in 2020
3.6 Conclusion of Segment by Type
Chapter 4 Biopharmaceutical CMO & CRO Market Segment Analysis by Application
4.1 Global Biopharmaceutical CMO & CRO Market by Application
4.1.1 Biologics
4.1.2 Biosimilars
4.2 Global Biopharmaceutical CMO & CRO Revenue and Market Share by Application (2015-2020)
4.3 Leading Consumers of Biopharmaceutical CMO & CRO by Application in 2020
4.4 Conclusion of Segment by Application
Chapter 5 Biopharmaceutical CMO & CRO Market Segment Analysis by Sales Channel
5.1 Global Biopharmaceutical CMO & CRO Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Biopharmaceutical CMO & CRO Revenue and Market Share by Sales Channel (2015-2020)
5.3 Leading Distributors/Dealers of Biopharmaceutical CMO & CRO by Sales Channel in 2020
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Biopharmaceutical CMO & CRO Market Segment Analysis by Region
6.1 Global Biopharmaceutical CMO & CRO Market Size and CAGR by Region (2015-2030)
6.2 Global Biopharmaceutical CMO & CRO Sales and Market Share by Region (2015-2020)
6.3 Global Biopharmaceutical CMO & CRO Revenue and Market Share by Region (2015-2020)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Biopharmaceutical CMO & CRO Market Share by Type
6.4.3 North America Biopharmaceutical CMO & CRO Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Biopharmaceutical CMO & CRO Market Share by Type
6.5.3 Europe Biopharmaceutical CMO & CRO Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Biopharmaceutical CMO & CRO Market Share by Type
6.6.3 Asia-Pacific Biopharmaceutical CMO & CRO Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Biopharmaceutical CMO & CRO Market Share by Type
6.7.3 South America Biopharmaceutical CMO & CRO Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Biopharmaceutical CMO & CRO Market Share by Type
6.8.3 Middle East & Africa Biopharmaceutical CMO & CRO Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Biopharmaceutical CMO & CRO Players
7.1 Boehringer Ingelheim
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.1.4 COVID-19 Impact on Boehringer Ingelheim
7.2 Lonza
7.3 Inno Biologics
7.4 Rentschler Biotechnologie
7.5 JRS PHARMA
7.6 BIOMEVA
7.7 ProBioGen
7.8 FUJIFILM Diosynth Biotechnologies
7.9 TOYOBO
7.10 Samsung BioLogics
7.11 Thermo Fisher Scientific (Patheon)
7.12 AGC Biologics (CMC Biologics)
7.13 Binex
7.14 WuXi Biologics
7.15 AbbVie
7.16 Charles River Laboratories
7.17 ICON plc
7.18 Pharmaceutical Product Development
7.19 Laboratory Corporation of America Holdings
7.20 PAREXEL International Corporation
7.21 PRA Health Sciences
7.22 GenScript
7.23 IDTDNA
7.24 Eufin
7.25 TWIST
7.26 ABCam
7.27 BioRab
7.28 GeneWiz
Chapter 8 Upstream and Downstream Analysis of Biopharmaceutical CMO & CRO
8.1 Industrial Chain of Biopharmaceutical CMO & CRO
8.2 Upstream of Biopharmaceutical CMO & CRO
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.2.4 Manufacturing Cost Structure
8.2.5 Manufacturing Process
8.3 Downstream of Biopharmaceutical CMO & CRO
8.3.1 Leading Distributors/Dealers of Biopharmaceutical CMO & CRO
8.3.2 Leading Consumers of Biopharmaceutical CMO & CRO
Chapter 9 Development Trend of Biopharmaceutical CMO & CRO (2021-2030)
9.1 Global Biopharmaceutical CMO & CRO Market Size (Sales and Revenue) Forecast (2021-2030)
9.2 Global Biopharmaceutical CMO & CRO Market Size and CAGR Forecast by Region (2021-2030)
9.3 Global Biopharmaceutical CMO & CRO Market Size and CAGR Forecast by Type (2021-2030)
9.4 Global Biopharmaceutical CMO & CRO Market Size and CAGR Forecast by Application (2021-2030)
9.5 Global Biopharmaceutical CMO & CRO Market Size and CAGR Forecast by Sales Channel (2021-2030)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification



Select License Type
Single User: USD 2500
Multiple User: USD 2900
Corporate User: USD 3500
Buy Now


Our Clients






Q. What is the scope of the report?

This market study covers the global and regional market with an
in-depth analysis of the overall growth prospects in the market.
Furthermore, it sheds light on the comprehensive competitive landscape
of the global market. The report further offers a dashboard overview of
leading companies encompassing their successful marketing strategies,
market contribution, recent developments in both historic and present
contexts.


Q. What are the key segments in the market?

  • By product type
  • By End User/Applications
  • By Regions


Q. Which market dynamics affect the business?

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.



FAQ




Stay Update!!!

Follow Us

Popular Links

Get In Touch

1321 Upland Dr. PMB 20205, Houston, Texas, 77043, US

sales@fusionmarketresearch.com

+1 210-775-2636 (USA)

© Fusion Market Research . All Rights Reserved.